Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences Inc (NQ: SAVA )

22.14 +0.04 (+0.18%)
Streaming Delayed Price Updated: 2:03 PM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cassava Sciences Inc

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Why Centene Stock Was Up 19% in May
New executives and confirmation that an acquisition will close soon sparked a rally in the shares. 
Via The Motley Fool
Why Cassava Sciences Was Up 15% in May
Thanks to key funding, its Alzheimer's drug is on track even after Biogen's historic approval. 
Via The Motley Fool
Forget Biogen: These 2 Alzheimer's Drug Stocks Could Make You Rich
There are better options for investors looking to profit from potential Alzheimer's disease treatments. 
Via The Motley Fool
Exposures Product Safety
Biogen Wins Landmark Alzheimer's Approval: 5 Things To Know About Aducanumab
The FDA approved Biogen's Alzheimer's treatment, aducanumab, on Monday — though Biogen stock remained halted into the long-awaited decision. 
Via Investor's Business Daily
Exposures Product Safety
Annovis Bio Stock Rockets As Alzheimer's Drug Tops Biogen, Cassava Sciences
Annovis Bio said Friday its experimental Alzheimer's and Parkinson's treatment improved cognition in less than a month, leading ANVS stock to soar. 
Via Investor's Business Daily
The Fight Against Alzheimer's Reaches A Moment Of Truth For Biogen, Other Biotech Stocks
The FDA will soon review aducanumab, possibly the first new Alzheimer's treatment in years. Stakes are high for Biogen stock — and other biotech stocks too. 
Via Investor's Business Daily
Exposures Product Safety
Caladrius Biosciences, Cassava Sciences Secure Non-Dilutive Funding For Product Development
Caladrius Biosciences Inc (NASDAQ: CLBS) has received $1.4 million in non-dilutive funding as an approved participant of the Technology Business Tax... 
Via Benzinga
Biden's Budget May Boost These 3 Biotechs
It signals a big push toward curing a neurological disease with a massive market. 
Via The Motley Fool
Exposures COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2021
Upgrades According to JP Morgan, the prior rating for BP Midstream Partners LP (NYSE:BPMP) was changed from Neutral to Overweight. For the fourth quarter, BP Midstream... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Aldeyra Therapeutics (NASDAQ:ALDX) stock moved upwards by 25.29% to $13.92 during Tuesday's pre-market session. The company's market cap stands at $661.8... 
Via Benzinga
Alzheimer's Disease: 5 Stocks on Biotech Radars
What's been interesting for the past couple of years, and especially the last few months, is to watch the rise of emerging, small-cap Biotech companies trying to take on the big AD and other... 
Via Talk Markets
48 Biggest Movers From Yesterday
Gainers Welbilt, Inc. (NYSE: WBT) shares surged 44.5% to close at $22.58 on Wednesday after The Middleby Corporation announced plans to acquire the company. Skillz Inc. (NYSE:... 
Via Benzinga
Mid-Afternoon Market Update: Dow Jumps 250 Points; Netflix Shares Slide
Toward the end of trading Wednesday, the Dow traded up 0.75% to 34,073.66 while the NASDAQ rose 0.70% to 13,882.45. The S&P also rose, gaining 0.64% to 4,161.25. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Mid-Day Market Update: Welbilt Surges Following Acquisition News; Unique Fabricating Shares Plummet
Midway through trading Wednesday, the Dow traded up 0.62% to 34,029.67 while the NASDAQ rose 0.31% to 13,829.69. The S&P also rose, gaining 0.43% to 4,152.82. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
33 Stocks Moving In Wednesday's Mid-Day Session
Gainers Welbilt, Inc. (NYSE: WBT) shares jumped 34.8% to $21.06 after The Middleby Corporation announced plans to acquire the company. Acme United Corporation (NYSE: ACU) gained... 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.